...
tngx-img

Tango Therapeutics Inc, Common Stock

TNGX

NMQ

$2.842

-$0.07

(-2.41%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$312.59M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
576.04K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.88
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$2.7 L
$13.01 H
$2.842

About Tango Therapeutics Inc, Common Stock

Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 that is being developed as a treatment for cancers with methylthioadenosine phosphorylase deletions. The company develops TNG462, an oral small molecule methylthioadenosine-cooperative inhibitor for the treatment for cancers with methylthioadenosine phosphorylase deletions; TNG260, a co-repressor of repressor element-1 silencing transcription -selective inhibitor; TNG348, an ubiquitin-specific protease 1 inhibitor to treat patients with BRCA1 or BRCA2-mutant cancers; and Target 3 for STK11-mutant cancers. It has a strategic collaboration with Gilead Sciences, Inc. for the discovery, development, and commercialization of a pipeline of therapies for patients with cancer. Tango Therapeutics, Inc. was founded in 2017 and is headquartered in Boston, Massachusetts. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameTNGXSectorS&P500
1-Week Return-12.08%-3.39%0.2%
1-Month Return-19.17%-1.92%2.72%
3-Month Return-66.24%-10.54%7.31%
6-Month Return-68.98%-4.47%10.44%
1-Year Return-72.02%4.06%27.53%
3-Year Return-73.55%0.94%30.88%
5-Year Return-71.55%36.67%89.21%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue24.65M7.66M37.04M24.86M36.53M[{"date":"2019-12-31","value":66.54,"profit":true},{"date":"2020-12-31","value":20.67,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":67.11,"profit":true},{"date":"2023-12-31","value":98.61,"profit":true}]
Cost of Revenue31.46M1.63M1.97M4.03M115.20M[{"date":"2019-12-31","value":27.31,"profit":true},{"date":"2020-12-31","value":1.41,"profit":true},{"date":"2021-12-31","value":1.71,"profit":true},{"date":"2022-12-31","value":3.5,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Profit(6.81M)6.03M37.04M24.86M(78.67M)[{"date":"2019-12-31","value":-18.38,"profit":false},{"date":"2020-12-31","value":16.28,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":67.11,"profit":true},{"date":"2023-12-31","value":-212.38,"profit":false}]
Gross Margin(27.62%)78.77%100.00%100.00%(215.38%)[{"date":"2019-12-31","value":-27.62,"profit":false},{"date":"2020-12-31","value":78.77,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-215.38,"profit":false}]
Operating Expenses7.97M59.86M95.23M135.93M150.70M[{"date":"2019-12-31","value":5.29,"profit":true},{"date":"2020-12-31","value":39.72,"profit":true},{"date":"2021-12-31","value":63.19,"profit":true},{"date":"2022-12-31","value":90.2,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income(15.16M)(52.20M)(58.19M)(111.07M)(114.17M)[{"date":"2019-12-31","value":-1516200000,"profit":false},{"date":"2020-12-31","value":-5220000000,"profit":false},{"date":"2021-12-31","value":-5819000000,"profit":false},{"date":"2022-12-31","value":-11107100000,"profit":false},{"date":"2023-12-31","value":-11417300000,"profit":false}]
Total Non-Operating Income/Expense-336.00K742.00K4.41M17.54M[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":1.92,"profit":true},{"date":"2021-12-31","value":4.23,"profit":true},{"date":"2022-12-31","value":25.12,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Pre-Tax Income(14.10M)(51.97M)(57.94M)(108.12M)(101.61M)[{"date":"2019-12-31","value":-1409500000,"profit":false},{"date":"2020-12-31","value":-5197200000,"profit":false},{"date":"2021-12-31","value":-5794300000,"profit":false},{"date":"2022-12-31","value":-10812200000,"profit":false},{"date":"2023-12-31","value":-10161000000,"profit":false}]
Income Taxes-(108.00K)292.00K54.00K134.00K[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-36.99,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":18.49,"profit":true},{"date":"2023-12-31","value":45.89,"profit":true}]
Income After Taxes-(51.86M)(58.23M)(108.18M)(101.74M)[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-5186400000,"profit":false},{"date":"2021-12-31","value":-5823500000,"profit":false},{"date":"2022-12-31","value":-10817600000,"profit":false},{"date":"2023-12-31","value":-10174400000,"profit":false}]
Income From Continuous Operations-(51.97M)(58.23M)(108.18M)(100.04M)[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-5197200000,"profit":false},{"date":"2021-12-31","value":-5823500000,"profit":false},{"date":"2022-12-31","value":-10817600000,"profit":false},{"date":"2023-12-31","value":-10004100000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(14.10M)(51.86M)(58.23M)(108.18M)(101.74M)[{"date":"2019-12-31","value":-1409500000,"profit":false},{"date":"2020-12-31","value":-5186400000,"profit":false},{"date":"2021-12-31","value":-5823500000,"profit":false},{"date":"2022-12-31","value":-10817600000,"profit":false},{"date":"2023-12-31","value":-10174400000,"profit":false}]
EPS (Diluted)-(0.01)(0.70)(1.23)(1.10)[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-0.58,"profit":false},{"date":"2021-12-31","value":-70,"profit":false},{"date":"2022-12-31","value":-123,"profit":false},{"date":"2023-12-31","value":-110,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

TNGX
Cash Ratio 7.80
Current Ratio 8.00

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

TNGX
ROA (LTM) -22.37%
ROE (LTM) -48.79%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

TNGX
Debt Ratio Lower is generally better. Negative is bad. 0.35
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.65

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

TNGX
Trailing PE NM
Forward PE NM
P/S (TTM) 7.21
P/B 1.36
Price/FCF NM
EV/R 1.31
EV/Ebitda NM

FAQs

What is Tango Therapeutics Inc share price today?

Tango Therapeutics Inc (TNGX) share price today is $2.842

Can Indians buy Tango Therapeutics Inc shares?

Yes, Indians can buy shares of Tango Therapeutics Inc (TNGX) on Vested. To buy Tango Therapeutics Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in TNGX stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Tango Therapeutics Inc be purchased?

Yes, you can purchase fractional shares of Tango Therapeutics Inc (TNGX) via the Vested app. You can start investing in Tango Therapeutics Inc (TNGX) with a minimum investment of $1.

How to invest in Tango Therapeutics Inc shares from India?

You can invest in shares of Tango Therapeutics Inc (TNGX) via Vested in three simple steps:

  • Click on Sign Up or Invest in TNGX stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Tango Therapeutics Inc shares
What is Tango Therapeutics Inc 52-week high and low stock price?

The 52-week high price of Tango Therapeutics Inc (TNGX) is $13.01. The 52-week low price of Tango Therapeutics Inc (TNGX) is $2.7.

What is Tango Therapeutics Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Tango Therapeutics Inc (TNGX) is

What is Tango Therapeutics Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Tango Therapeutics Inc (TNGX) is 1.36

What is Tango Therapeutics Inc dividend yield?

The dividend yield of Tango Therapeutics Inc (TNGX) is 0.00%

What is the Market Cap of Tango Therapeutics Inc?

The market capitalization of Tango Therapeutics Inc (TNGX) is $312.59M

What is Tango Therapeutics Inc’s stock symbol?

The stock symbol (or ticker) of Tango Therapeutics Inc is TNGX

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top